Pahtiā Technologies Inc.

Our mission is to help save lives on a global scale. 

We are revolutionizing access to genomic insights for cancer by leveraging next-generation sequencing and artificial intelligence. 

We want to ensure that everyone, regardless of background or country, benefits from personalized healthcare and life-saving cancer treatments.

We have built a robust platform that harnesses the power of next-generation sequencing (NGS) and artificial intelligence (AI) to unlock the secrets hidden within the human genome. NGS technology provides unparalleled depth and accuracy, while our AI-driven biomarker discovery platform identifies complex patterns and generates actionable insights. This combination allows us to deliver personalized genomic profiles with unprecedented speed and efficiency.

Cancer inequity exists around the world. Options for cancer treatment depend on where you live and genomic research has predominantly focused on populations of European descent, leaving under-researched communities without vital insights. This disparity leads to missed opportunities for personalized prevention, diagnosis, and treatment. 

We are changing that. Our company combines cutting-edge next-generation sequencing with powerful artificial intelligence to analyze diverse genomic data, delivering equitable access to life-changing information.